Junhao Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Junhao Zhu has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Eric J. Rubin
Harvard Chan School of Public Health, Department of Immunology and Infectious Diseases, Harvard University, Cambridge, MA, USA
13 shared publications - Qingyun Liu
Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
8 shared publications - Sarah M. Fortune
Harvard University
7 shared publications - Charles L. Dulberger
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health
4 shared publications Ian D. Wolf
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health
4 shared publications- Harim I. Won
Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, USA
3 shared publications
Latest Publications
- Open Access
Parallel Emergence and Adaptive Evolution of Multicountry Circulating Mycobacterium abscessus Clones
Mycobacterium abscessus (MAB) is a recently emerged bacterial pathogen causing an increasing number of human infections. Despite increasing recognition that different circulating clones contribute disproportionately to MAB population expansion, the global population dynamics and the evolutionary pressures underlying the emergence and spread of MAB clones remain incompletely understood. We analyzed 11,314 publicly available genomes of MAB isolates sampled from 30 countries and identified 38 recently emerged clones that have spread across multiple countries, including the seven previously described Dominant Circulating Clones (DCCs). There was a significant association between the time since the emergence of each circulating clone and its population size, with older clones generally having larger populations. Among the 26 circulating clones of M. abscessus subsp. abscessus , 12 carried the macrolide-susceptible erm(41) 28C genotype, highlighting clone-level variation in macrolide susceptibility. Genome-wide analyses identified 55 genes that were previously under purifying selection but showed evidence of positive selection during recent clade expansion. Collectively, our findings reveal that the recent global expansion of MAB comprises a broad continuum of newly emerged clones, accompanied by widespread shifts in gene-level selective pressures indicative of ongoing adaptation to new ecological environments.
Open AccessParallel Emergence and Adaptive Evolution of Multicountry Circulating Mycobacterium abscessus Clones
Mycobacterium abscessus (MAB) is a recently emerged bacterial pathogen causing an increasing number of human infections. Despite increasing recognition that different circulating clones contribute disproportionately to MAB population expansion, the global population dynamics and the evolutionary pressures underlying the emergence and spread of MAB clones remain incompletely understood. We analyzed 11,314 publicly available genomes of MAB isolates sampled from 30 countries and identified 38 recently emerged clones that have spread across multiple countries, including the seven previously described Dominant Circulating Clones (DCCs). There was a significant association between the time since the emergence of each circulating clone and its population size, with older clones generally having larger populations. Among the 26 circulating clones of M. abscessus subsp. abscessus , 12 carried the macrolide-susceptible erm(41) 28C genotype, highlighting clone-level variation in macrolide susceptibility. Genome-wide analyses identified 55 genes that were previously under purifying selection but showed evidence of positive selection during recent clade expansion. Collectively, our findings reveal that the recent global expansion of MAB comprises a broad continuum of newly emerged clones, accompanied by widespread shifts in gene-level selective pressures indicative of ongoing adaptation to new ecological environments.
- Open Access
- 18 November 2025
- Published by American Society for Microbiology in mSystems
- Vol. 10 (11) , e0097225
High-throughput cytological profiling uncovers genotype-phenotype associations in Mycobacterium tuberculosis clinical isolates
Understanding the functional impact of bacterial genetic diversity is crucial for linking pathogen variants to clinical outcomes. Here, we introduce a high-throughput cytological profiling pipeline optimized for Mycobacterium tuberculosis (Mtb) clinical strains, integrating OD-calibrated feature analysis and high-content microscopy. Our system quantifies single-bacterium morphological and physiological traits related to DNA replication, redox state, carbon metabolism, and cell envelope dynamics. Applied to 64 Mtb clinical isolates from lineages 1, 2, and 4, the approach revealed that cytological phenotypes recapitulate genetic relationships and exhibit both lineage- and density-dependent dynamics. Notably, we identified a link between a convergent “small cell” phenotype and a convergent ino1 mutation that is associated with the presence of an antisense transcript, suggesting a potential non-canonical regulatory mechanism under selection. In summary, we present a resource-efficient approach for mapping Mtb’s phenotypic landscape, uncovering cellular traits that underlie its evolution and providing new insights into the functional consequences of bacterial genetic diversity. IMPORTANCE: Understanding how genetic variation in Mycobacterium tuberculosis (Mtb) shapes its physical traits is essential to unraveling the evolution of this global pathogen. Here, we introduce a systematically optimized, high-throughput imaging platform for the comprehensive characterization of Mtb clinical strains. We demonstrate that Mtb’s phenotypic manifestation is shaped by both genetic background and culture density. By accounting for these factors, our analysis linked distinct cellular dynamics to specific lineages, sublineages, and even single nucleotide variations. Notably, we linked a recurring mutation to a unique cell-shortening phenotype, finding that it potentially acts by creating a cryptic antisense transcript. This platform provides a powerful framework for systematically dissecting the physiological dynamics underlying Mtb evolution and identifying new therapeutic vulnerabilities of this deadly pathogen.
- 18 November 2025
- Published by American Society for Microbiology in mSystems
- Vol. 10 (11) , e0097225
Open AccessHigh-throughput cytological profiling uncovers genotype-phenotype associations in Mycobacterium tuberculosis clinical isolates
Understanding the functional impact of bacterial genetic diversity is crucial for linking pathogen variants to clinical outcomes. Here, we introduce a high-throughput cytological profiling pipeline optimized for Mycobacterium tuberculosis (Mtb) clinical strains, integrating OD-calibrated feature analysis and high-content microscopy. Our system quantifies single-bacterium morphological and physiological traits related to DNA replication, redox state, carbon metabolism, and cell envelope dynamics. Applied to 64 Mtb clinical isolates from lineages 1, 2, and 4, the approach revealed that cytological phenotypes recapitulate genetic relationships and exhibit both lineage- and density-dependent dynamics. Notably, we identified a link between a convergent “small cell” phenotype and a convergent ino1 mutation that is associated with the presence of an antisense transcript, suggesting a potential non-canonical regulatory mechanism under selection. In summary, we present a resource-efficient approach for mapping Mtb’s phenotypic landscape, uncovering cellular traits that underlie its evolution and providing new insights into the functional consequences of bacterial genetic diversity. IMPORTANCE: Understanding how genetic variation in Mycobacterium tuberculosis (Mtb) shapes its physical traits is essential to unraveling the evolution of this global pathogen. Here, we introduce a systematically optimized, high-throughput imaging platform for the comprehensive characterization of Mtb clinical strains. We demonstrate that Mtb’s phenotypic manifestation is shaped by both genetic background and culture density. By accounting for these factors, our analysis linked distinct cellular dynamics to specific lineages, sublineages, and even single nucleotide variations. Notably, we linked a recurring mutation to a unique cell-shortening phenotype, finding that it potentially acts by creating a cryptic antisense transcript. This platform provides a powerful framework for systematically dissecting the physiological dynamics underlying Mtb evolution and identifying new therapeutic vulnerabilities of this deadly pathogen.
- Open Access
- 31 August 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (5)
A transcriptional plasticity-aware framework for RNA-seq differential expression analysis
Differential expression (DE) analysis based on transcriptomic data provides a genome-wide assessment of gene responsiveness. We recently characterized transcriptional plasticity (TP)—the variability of gene expression in response to environmental changes—but its impact on DE analysis remained unexplored. In this work, we examined how TP affects DE analysis and introduced a TP-aware framework to improve the interpretation of DE results. We revealed correlations between fold change of gene expression and TP in 238 experiments with Mycobacterium tuberculosis (Mtb) and Escherichia coli (E. coli), which carried inherent biases, favoring genes with high TP while overlooking those with low TP. Therefore, we employed Locally Estimated Scatterplot Smoothing on TP to adjust the fold change of gene expression. Adjusted DE analyses identified new responsive pathways and yielded higher overall statistical significance and enrichment scores, especially for pathways with low-TP genes. Specifically, adjusted DE results revealed that bedaquiline treatment of Mtb induced cholesterol degradation, linezolid repressed acetate metabolism, and infection of macrophages upregulated fatty acid metabolism while downregulating cofactor biosynthesis. We also demonstrate that the adjustment strategy can be applied to other bacterial species and is compatible with various RNA-seq quantification approaches. In summary, we introduce a TP-aware approach that normalizes DE analysis by correcting for inherent transcriptional variability.
- 31 August 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (5)
Open AccessA transcriptional plasticity-aware framework for RNA-seq differential expression analysis
Differential expression (DE) analysis based on transcriptomic data provides a genome-wide assessment of gene responsiveness. We recently characterized transcriptional plasticity (TP)—the variability of gene expression in response to environmental changes—but its impact on DE analysis remained unexplored. In this work, we examined how TP affects DE analysis and introduced a TP-aware framework to improve the interpretation of DE results. We revealed correlations between fold change of gene expression and TP in 238 experiments with Mycobacterium tuberculosis (Mtb) and Escherichia coli (E. coli), which carried inherent biases, favoring genes with high TP while overlooking those with low TP. Therefore, we employed Locally Estimated Scatterplot Smoothing on TP to adjust the fold change of gene expression. Adjusted DE analyses identified new responsive pathways and yielded higher overall statistical significance and enrichment scores, especially for pathways with low-TP genes. Specifically, adjusted DE results revealed that bedaquiline treatment of Mtb induced cholesterol degradation, linezolid repressed acetate metabolism, and infection of macrophages upregulated fatty acid metabolism while downregulating cofactor biosynthesis. We also demonstrate that the adjustment strategy can be applied to other bacterial species and is compatible with various RNA-seq quantification approaches. In summary, we introduce a TP-aware approach that normalizes DE analysis by correcting for inherent transcriptional variability.
- Open Access
RNA polymerase-mediated regulation of intrinsic antibiotic resistance and bacterial cell division
Rifampin is a frontline antibiotic that inhibits the RNA polymerase of Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). Unlike most antibiotics, rifampin has an unusual ability to shorten the duration of treatment needed to cure TB that is not simply explained by its antimicrobial potency. We sought specific secondary effects of rifampin’s inhibition of Mtb RNA polymerase that may mediate this activity. We discovered that rifampin elicited a cell division arrest that was mediated through its inhibition of RNA polymerase. This arrest resulted in a downstream inhibition of the MtrAB two-component regulatory system, a mediator of intrinsic antibiotic resistance in Mtb. This inhibition is broadly conserved in other bacteria and represents a novel form of antimicrobial activity, termed adjunctive sensitization, that can mediate synergy and may contribute to rifampin’s unusual treatment shortening activity.
Open AccessRNA polymerase-mediated regulation of intrinsic antibiotic resistance and bacterial cell division
Rifampin is a frontline antibiotic that inhibits the RNA polymerase of Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). Unlike most antibiotics, rifampin has an unusual ability to shorten the duration of treatment needed to cure TB that is not simply explained by its antimicrobial potency. We sought specific secondary effects of rifampin’s inhibition of Mtb RNA polymerase that may mediate this activity. We discovered that rifampin elicited a cell division arrest that was mediated through its inhibition of RNA polymerase. This arrest resulted in a downstream inhibition of the MtrAB two-component regulatory system, a mediator of intrinsic antibiotic resistance in Mtb. This inhibition is broadly conserved in other bacteria and represents a novel form of antimicrobial activity, termed adjunctive sensitization, that can mediate synergy and may contribute to rifampin’s unusual treatment shortening activity.
- Open Access
- 4 March 2025
- Published by Oxford University Press (OUP) in Protein & Cell
Pasteurized Akkermansia muciniphila promotes GP2 expression in microfold cells and facilitates Salmonella infection
- 4 March 2025
- Published by Oxford University Press (OUP) in Protein & Cell
Open AccessPasteurized Akkermansia muciniphila promotes GP2 expression in microfold cells and facilitates Salmonella infection
- Open Access
- 29 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Paired analysis of host and pathogen genomes identifies determinants of human tuberculosis
Infectious disease is the result of interactions between host and pathogen and can depend on genetic variations in both. We conduct a genome-to-genome study of paired human and Mycobacterium tuberculosis genomes from a cohort of 1556 tuberculosis patients in Lima, Peru. We identify an association between a human intronic variant (rs3130660, OR = 10.06, 95%CI: 4.87 − 20.77, P = 7.92 × 10−8) in the FLOT1 gene and a subclavaluee of Mtb Lineage 2. In a human macrophage infection model, we observe hosts with the rs3130660-A allele exhibited stronger interferon gene signatures. The interacting strains have altered redox states due to a thioredoxin reductase mutation. We investigate this association in a 2020 cohort of 699 patients recruited during the COVID-19 pandemic. While the prevalence of the interacting strain almost doubled between 2010 and 2020, its infection is not associated with rs3130660 in this recent cohort. These findings suggest a complex interplay among host, pathogen, and environmental factors in tuberculosis dynamics.
- 29 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Open AccessPaired analysis of host and pathogen genomes identifies determinants of human tuberculosis
Infectious disease is the result of interactions between host and pathogen and can depend on genetic variations in both. We conduct a genome-to-genome study of paired human and Mycobacterium tuberculosis genomes from a cohort of 1556 tuberculosis patients in Lima, Peru. We identify an association between a human intronic variant (rs3130660, OR = 10.06, 95%CI: 4.87 − 20.77, P = 7.92 × 10−8) in the FLOT1 gene and a subclavaluee of Mtb Lineage 2. In a human macrophage infection model, we observe hosts with the rs3130660-A allele exhibited stronger interferon gene signatures. The interacting strains have altered redox states due to a thioredoxin reductase mutation. We investigate this association in a 2020 cohort of 699 patients recruited during the COVID-19 pandemic. While the prevalence of the interacting strain almost doubled between 2010 and 2020, its infection is not associated with rs3130660 in this recent cohort. These findings suggest a complex interplay among host, pathogen, and environmental factors in tuberculosis dynamics.
- Open Access
- 14 May 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Targeted protein degradation in mycobacteria uncovers antibacterial effects and potentiates antibiotic efficacy
Proteolysis-targeting chimeras (PROTACs) represent a new therapeutic modality involving selectively directing disease-causing proteins for degradation through proteolytic systems. Our ability to exploit targeted protein degradation (TPD) for antibiotic development remains nascent due to our limited understanding of which bacterial proteins are amenable to a TPD strategy. Here, we use a genetic system to model chemically-induced proximity and degradation to screen essential proteins in Mycobacterium smegmatis (Msm), a model for the human pathogen M. tuberculosis (Mtb). By integrating experimental screening of 72 protein candidates and machine learning, we find that drug-induced proximity to the bacterial ClpC1P1P2 proteolytic complex leads to the degradation of many endogenous proteins, especially those with disordered termini. Additionally, TPD of essential Msm proteins inhibits bacterial growth and potentiates the effects of existing antimicrobial compounds. Together, our results provide biological principles to select and evaluate attractive targets for future Mtb PROTAC development, as both standalone antibiotics and potentiators of existing antibiotic efficacy.
- 14 May 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Open AccessTargeted protein degradation in mycobacteria uncovers antibacterial effects and potentiates antibiotic efficacy
Proteolysis-targeting chimeras (PROTACs) represent a new therapeutic modality involving selectively directing disease-causing proteins for degradation through proteolytic systems. Our ability to exploit targeted protein degradation (TPD) for antibiotic development remains nascent due to our limited understanding of which bacterial proteins are amenable to a TPD strategy. Here, we use a genetic system to model chemically-induced proximity and degradation to screen essential proteins in Mycobacterium smegmatis (Msm), a model for the human pathogen M. tuberculosis (Mtb). By integrating experimental screening of 72 protein candidates and machine learning, we find that drug-induced proximity to the bacterial ClpC1P1P2 proteolytic complex leads to the degradation of many endogenous proteins, especially those with disordered termini. Additionally, TPD of essential Msm proteins inhibits bacterial growth and potentiates the effects of existing antimicrobial compounds. Together, our results provide biological principles to select and evaluate attractive targets for future Mtb PROTAC development, as both standalone antibiotics and potentiators of existing antibiotic efficacy.
- Open Access
- 10 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Genetically encoded transcriptional plasticity underlies stress adaptation in Mycobacterium tuberculosis
Transcriptional regulation is a critical adaptive mechanism that allows bacteria to respond to changing environments, yet the concept of transcriptional plasticity (TP) – the variability of gene expression in response to environmental changes – remains largely unexplored. In this study, we investigate the genome-wide TP profiles of Mycobacterium tuberculosis (Mtb) genes by analyzing 894 RNA sequencing samples derived from 73 different environmental conditions. Our data reveal that Mtb genes exhibit significant TP variation that correlates with gene function and gene essentiality. We also find that critical genetic features, such as gene length, GC content, and operon size independently impose constraints on TP, beyond trans-regulation. By extending our analysis to include two other Mycobacterium species -- M. smegmatis and M. abscessus -- we demonstrate a striking conservation of the TP landscape. This study provides a comprehensive understanding of the TP exhibited by mycobacteria genes, shedding light on this significant, yet understudied, genetic feature encoded in bacterial genomes.
- 10 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Open AccessGenetically encoded transcriptional plasticity underlies stress adaptation in Mycobacterium tuberculosis
Transcriptional regulation is a critical adaptive mechanism that allows bacteria to respond to changing environments, yet the concept of transcriptional plasticity (TP) – the variability of gene expression in response to environmental changes – remains largely unexplored. In this study, we investigate the genome-wide TP profiles of Mycobacterium tuberculosis (Mtb) genes by analyzing 894 RNA sequencing samples derived from 73 different environmental conditions. Our data reveal that Mtb genes exhibit significant TP variation that correlates with gene function and gene essentiality. We also find that critical genetic features, such as gene length, GC content, and operon size independently impose constraints on TP, beyond trans-regulation. By extending our analysis to include two other Mycobacterium species -- M. smegmatis and M. abscessus -- we demonstrate a striking conservation of the TP landscape. This study provides a comprehensive understanding of the TP exhibited by mycobacteria genes, shedding light on this significant, yet understudied, genetic feature encoded in bacterial genomes.
- Open Access
- 29 January 2024
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 30 (5) , 660-665
Anti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: A cohort study
- 29 January 2024
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 30 (5) , 660-665
Open AccessAnti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: A cohort study
- Open Access
- 18 September 2023
- Published by Springer Nature in Research Square
Genetically encoded transcriptional plasticity underlies stress adaptation in Mycobacterium tuberculosis
Transcriptional regulation is a critical adaptive mechanism that allows bacteria to respond to changing environments, yet the concept of transcriptional plasticity (TP) remains largely unexplored. In this study, we investigate the genome-wide TP profiles of Mycobacterium tuberculosis (Mtb) genes by analyzing 894 RNA sequencing samples derived from 73 different environmental conditions. Our data reveal that Mtb genes exhibit significant TP variation that correlates with gene function and gene essentiality. We also found that critical genetic features, such as gene length, GC content, and operon size independently impose constraints on TP, beyond trans-regulation. By extending our analysis to include two other Mycobacterium species -- M. smegmatis and M. abscessus -- we demonstrate a striking conservation of the TP landscape. This study provides a comprehensive understanding of the TP exhibited by mycobacteria genes, shedding light on this significant, yet understudied, genetic feature encoded in bacterial genomes.
- 18 September 2023
- Published by Springer Nature in Research Square
Open AccessGenetically encoded transcriptional plasticity underlies stress adaptation in Mycobacterium tuberculosis
Transcriptional regulation is a critical adaptive mechanism that allows bacteria to respond to changing environments, yet the concept of transcriptional plasticity (TP) remains largely unexplored. In this study, we investigate the genome-wide TP profiles of Mycobacterium tuberculosis (Mtb) genes by analyzing 894 RNA sequencing samples derived from 73 different environmental conditions. Our data reveal that Mtb genes exhibit significant TP variation that correlates with gene function and gene essentiality. We also found that critical genetic features, such as gene length, GC content, and operon size independently impose constraints on TP, beyond trans-regulation. By extending our analysis to include two other Mycobacterium species -- M. smegmatis and M. abscessus -- we demonstrate a striking conservation of the TP landscape. This study provides a comprehensive understanding of the TP exhibited by mycobacteria genes, shedding light on this significant, yet understudied, genetic feature encoded in bacterial genomes.